
07/27/2025
https://www.onclive.com/view/dr-j-nne-on-second-line-treatment-evolutions-in-egfr-mutated-nsclc
Pasi A. Jänne, MD, PhD, discusses changes to the second-line treatment paradigm and treatment decision-making factors for patients with EGFR-mutated NSCLC.